当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析 - 现金流量表

宏源药业

(301246)

  

流通市值:54.94亿  总市值:129.20亿
流通股本:1.70亿   总股本:4.00亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金259,322,027.831,023,470,542.97798,157,077.42487,934,049.15
  收到的税费返还3,238,494.3724,931,822.624,837,813.6318,370,220.75
  收到其他与经营活动有关的现金6,796,891.4371,221,535.1522,678,257.9118,249,538.49
  经营活动现金流入小计269,357,413.631,119,623,900.72845,673,148.96524,553,808.39
  购买商品、接受劳务支付的现金137,778,866.34956,127,643.01790,227,503.57517,968,616.37
  支付给职工以及为职工支付的现金71,352,928.2219,961,860.47163,503,294.83111,522,550.54
  支付的各项税费32,158,716.954,268,753.7327,265,918.3222,688,800.18
  支付其他与经营活动有关的现金38,558,415.0774,227,669.6550,066,353.3441,888,389.8
  经营活动现金流出小计279,848,926.511,304,585,926.861,031,063,070.06694,068,356.89
  经营活动产生的现金流量净额-10,491,512.88-184,962,026.14-185,389,921.1-169,514,548.5
二、投资活动产生的现金流量:
  收回投资收到的现金431,901,018.775,387,349,572.354,184,646,241.392,621,620,299.07
  处置固定资产、无形资产和其他长期资产收回的现金净额473,183.722,114,836.971,834,205.94186,187.62
  投资活动现金流入小计432,374,202.495,389,464,409.324,186,480,447.332,621,806,486.69
  购建固定资产、无形资产和其他长期资产支付的现金57,100,870.27156,093,034.64131,292,020.4756,645,483.6
  投资支付的现金573,900,0005,474,000,0004,697,000,0002,907,300,000
  投资活动现金流出小计631,000,870.275,630,093,034.644,828,292,020.472,963,945,483.6
  投资活动产生的现金流量净额-198,626,667.78-240,628,625.32-641,811,573.14-342,138,996.91
三、筹资活动产生的现金流量:
  取得借款收到的现金81,750,657.99504,553,476.5448,000,000338,000,000
  收到其他与筹资活动有关的现金-78,545,949.5160,037,678.0143,042,716.38
  筹资活动现金流入小计81,750,657.99583,099,426.01508,037,678.01381,042,716.38
  偿还债务支付的现金22,777,000307,914,000133,054,00060,277,000
  分配股利、利润或偿付利息支付的现金3,905,516.4928,071,456.1123,532,444.1318,177,935.96
  支付其他与筹资活动有关的现金44,364,909.8715,766,629.1915,346,726.3232,458,014.39
  筹资活动现金流出小计71,047,426.36351,752,085.3171,933,170.45110,912,950.35
  筹资活动产生的现金流量净额10,703,231.63231,347,340.71336,104,507.56270,129,766.03
四、汇率变动对现金及现金等价物的影响-1,500,551.33-354,941.99581,007.55495,696.86
五、现金及现金等价物净增加额-199,915,500.36-194,598,252.74-490,515,979.13-241,028,082.52
  加:期初现金及现金等价物余额387,588,125.28582,186,378.02582,186,378.02582,186,378.02
  期末现金及现金等价物余额187,672,624.92387,588,125.2891,670,398.89341,158,295.5
补充资料:
  净利润-117,629,722.13--6,408,271.22
  资产减值准备-43,588,289.49-26,054,288.41
  固定资产和投资性房地产折旧-196,057,535.17-95,647,658.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-196,057,535.17-95,647,658.86
  无形资产摊销-5,457,289.29-2,385,489.47
  长期待摊费用摊销-2,686,474.6-1,427,568.19
  处置固定资产、无形资产和其他长期资产的损失--773,836.31--67,192.75
  固定资产报废损失-10,810,117.93-253,474.37
  公允价值变动损失--1,849,195.72--812,583.52
  财务费用-15,546,559.14-5,977,442.41
  投资损失--30,104,189.56--63,026.25
  递延所得税--2,297,864.27--1,495,838.04
  其中:递延所得税资产减少--2,408,607.98--1,598,485.01
    递延所得税负债增加-110,743.71-102,646.97
  存货的减少--54,126,972.35--49,839,346.94
  经营性应收项目的减少--579,111,126.27--218,683,753.19
  经营性应付项目的增加-79,469,220.22--24,376,011.08
  其他-11,084,844.81--
  现金的期末余额-387,588,125.28-341,158,295.5
  减:现金的期初余额-582,186,378.02-582,186,378.02
  现金及现金等价物的净增加额--194,598,252.74--241,028,082.52
公告日期2026-04-292026-04-292025-10-232025-08-28
审计意见(境内)标准无保留意见
TOP↑